2021 ACOG Annual Clinical and Scientific Meeting

Virtual 30 April 2021 - 02 May 2021

Efficacy, safety of levonorgestrel-releasing intrauterine system sustained at 6–7 years

08 Jun 2021 by

Year 6 and 7 cumulative data from the Mirena Extension Trial suggest that the efficacy and safety of the levonorgestrel-releasing intrauterine system (LNG-IUS) as a contraceptive method is maintained over this time frame.

Efficacy, safety of levonorgestrel-releasing intrauterine system sustained at 6–7 years

08 Jun 2021

Mifepristone-misoprostol combo shortens time to delivery during late pregnancy loss

27 May 2021 by

Administration of mifepristone, followed by misoprostol, shortened induction-to-delivery intervals in women who lost their babies during the third trimester of pregnancy compared with misoprostol alone, results of a systematic review has shown.

Mifepristone-misoprostol combo shortens time to delivery during late pregnancy loss

27 May 2021

Ibrexafungerp shows promise as first non-azole treatment for vulvovaginal candidiasis

21 May 2021 by

The novel oral triterpenoid antifungal ibrexafungerp demonstrated superiority over placebo in reducing signs and symptoms of vulvovaginal candidiasis, according to results of the phase III VANISH-306 trial presented at ACOG 2021.

Ibrexafungerp shows promise as first non-azole treatment for vulvovaginal candidiasis

21 May 2021

Lack of reproductive aged women in COVID-19 trials has long-ranging effects

19 May 2021 by

Women of reproductive age are often excluded from COVID-19 vaccine and treatment clinical trials, which could hinder their access to beneficial treatments, according to a study presented at the recent ACOG 2021 meeting.

Lack of reproductive aged women in COVID-19 trials has long-ranging effects

19 May 2021